From October 28 to 30. 2025. the global pharmaceutical industry's annual flagship event—CPHI Frankfurt 2025—successfully concluded at the Frankfurt International Exhibition Center. As a professional exhibition covering the entire industry chain, including active pharmaceutical ingredients, pharmaceutical equipment, and contract manufacturing, this year's event attracted approximately 2.400 exhibitors and over 60.000 pharmaceutical professionals from around the world. Laviana Pharma made a remarkable appearance with its one-stop CDMO services.
CPHI Worldwide, as the largest professional exhibition in the global pharmaceutical industry, has been successfully held for over 30 editions. It covers the entire pharmaceutical supply chain process from APIs and pharmaceutical packaging equipment to finished dosage forms, and is recognized as the core exhibition and exchange platform by professionals in the global pharmaceutical ingredients industry. In addition to focusing on green pharmaceutical processes, the application of artificial intelligence technology in the pharmaceutical field has become another major highlight of this year's exhibition. More than 180 professional conferences and forums conducted in-depth discussions on new industry trends and challenges, charting the direction for the development of the global pharmaceutical industry.
As a global Contract Development and Manufacturing Organization (CDMO) for innovative pharmaceuticals, Laviana Pharma showcased multiple internationally competitive core achievements at this exhibition. Among them, high-value-added active pharmaceutical ingredients and key intermediates that strictly comply with international quality standards garnered significant attention. Simultaneously, the company highlighted its comprehensive contract customization service capabilities spanning from R&D to large-scale production, attracting numerous international clients for discussions with its professional technical expertise and flexible service model.
During the exhibition, the Laviana Pharma European business team fully demonstrated the company's comprehensive capabilities in pharmaceutical raw material R&D, production, and customized services to global clients through professional and detailed technical explanations and comprehensive product material displays. Additionally, the Laviana Pharma core technology team engaged in in-depth discussions with industry peers from around the world on multiple dimensions including technology transfer, joint development, green processes, customized production, and market access, actively exploring possibilities for deeper cooperation and injecting new momentum into building a more resilient global pharmaceutical supply chain.
After twenty years of project practice and technological accumulation, Laviana Pharma has continuously overcome key process challenges, providing leading industry solutions for global clients. This exhibition is an important step for the company to deepen its internationalization strategy. Looking ahead, Laviana Pharma will continue to strengthen its technological innovation system, expand its global service layout, and support the global pharmaceutical industry in reaching new heights with efficient, high-quality CDMO services.